Prostate Cancer
Conference Coverage
Healthy lifestyle may offset genetic risk in prostate cancer
In men at the highest risk of dying from prostate cancer, a healthy lifestyle cut the risk of fatal disease in half.
Conference Coverage
CCR score can guide treatment decisions after radiation in prostate cancer
The score can identify patients with a low risk of metastasis who could potentially skip androgen deprivation therapy.
Conference Coverage
Declines in PSA screening may account for rise in metastatic prostate cancers
Longitudinal reductions in PSA screening across U.S. states were associated with increased incidence of metastatic prostate cancer.
Original Research
Liquid Biopsies in a Veteran Patient Population With Advanced Prostate and Lung Non-Small Cell Carcinomas: A New Paradigm and Unique Challenge in Personalized Medicine
Minimally invasive liquid biopsy shows great promise as both a diagnostic and prognostic tool in the personalized clinical management of advanced...
News
FDA approves first agent for PSMA-PET imaging in prostate cancer
The diagnostic agent Gallium 68 PSMA-11 has been approved for institutional use only.
Original Research
The Effect of Radium-223 Therapy in Agent Orange-Related Prostate Carcinoma
Radium-223 radioisotope has been reported to increase median survival in bone metastatic prostate carcinoma; however, there have been no...
Conference Coverage
Cancer therapy affects sexual health in most patients